Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph S Ross

Showing results (31-40 of 797) with videos related to

Pageof 80
Sort By:
BMJ (Clinical Research Ed.)|May 4, 2017
US drug marketing: how does promotion correspond with health value?Tyler Greenway, Joseph S Ross
JAMA|May 2, 2017
Obstacles to the Adoption of Biosimilars for Chronic DiseasesAaron Hakim, Joseph S Ross
Postgraduate Medical Journal|May 20, 2014
Doctors and healthcare reform: a duty to understand?Theodore Long, Joseph S Ross
JAMA|May 28, 2026
Growth in Hospital-Led Payer Integration: Improving Care or Consolidating Markets?Jiani Yu, Joseph S Ross
JAMA Internal Medicine|July 9, 2019
Clinical Trial Evidence for the Real WorldJoseph S Ross, Ken Covinsky
JAMA Internal Medicine|January 24, 2017
High Prices for Drugs With Generic Alternatives: The Curious Case of DuexisAaron Hakim, Joseph S Ross
JAMA|July 17, 2019
The Bleeding Edge: Documenting Innovation and Injury in the Medical Device IndustryAkshay Pendyal, Joseph S Ross
JAMA|November 6, 2024
Enhancing Medical Device Postmarketing Safety Surveillance-The Case of Inferior Vena Cava FiltersBehnood Bikdeli, Joseph S Ross
Expert Opinion on Drug Discovery|March 15, 2013
The cost of pharmaceutical innovation to patientsSalomeh Keyhani, Joseph S Ross
JAMA|June 22, 2026
National Trends in Patient Messaging-The Growing Electronic InboxMelanie Molina, Joseph S Ross
Pageof 80

Showing results (31-40 of 797) with videos related to

Sort By:
Pageof 80
BMJ (Clinical Research Ed.)|May 4, 2017
US drug marketing: how does promotion correspond with health value?Tyler Greenway, Joseph S Ross
JAMA|May 2, 2017
Obstacles to the Adoption of Biosimilars for Chronic DiseasesAaron Hakim, Joseph S Ross
Postgraduate Medical Journal|May 20, 2014
Doctors and healthcare reform: a duty to understand?Theodore Long, Joseph S Ross
JAMA|May 28, 2026
Growth in Hospital-Led Payer Integration: Improving Care or Consolidating Markets?Jiani Yu, Joseph S Ross
JAMA Internal Medicine|July 9, 2019
Clinical Trial Evidence for the Real WorldJoseph S Ross, Ken Covinsky
JAMA Internal Medicine|January 24, 2017
High Prices for Drugs With Generic Alternatives: The Curious Case of DuexisAaron Hakim, Joseph S Ross
JAMA|July 17, 2019
The Bleeding Edge: Documenting Innovation and Injury in the Medical Device IndustryAkshay Pendyal, Joseph S Ross
JAMA|November 6, 2024
Enhancing Medical Device Postmarketing Safety Surveillance-The Case of Inferior Vena Cava FiltersBehnood Bikdeli, Joseph S Ross
Expert Opinion on Drug Discovery|March 15, 2013
The cost of pharmaceutical innovation to patientsSalomeh Keyhani, Joseph S Ross
JAMA|June 22, 2026
National Trends in Patient Messaging-The Growing Electronic InboxMelanie Molina, Joseph S Ross
Pageof 80